Kailun L. Fei

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100730, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery.

EGFR-targeting ADCs: From oncogene addiction to antigen-guided drug delivery.

Journal: Cancer cell

Published: June 27, 2026

Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis.

Genomic Profiling, Risk Stratification, and Post-Transformation Treatment Outcomes in Patients with Transformed Small-Cell Lung Cancer: A Multicenter Analysis.

Journal: Lung cancer (Amsterdam, Netherlands)

Published: May 05, 2026

Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Correction: Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Journal: Signal transduction and targeted therapy

Published: January 19, 2026

A multi-modal foundation model for brain disease diagnosis and medical imaging.

A multi-modal foundation model for brain disease diagnosis and medical imaging.

Journal: Patterns (New York, N.Y.)

Published: September 14, 2025

Study of the blood-brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases.

Study of the blood-brain barrier-penetrating KRAS G12C inhibitor JMKX1899 in KRAS G12C-mutated NSCLC with brain metastases.

Journal: Journal of the National Cancer Center

Published: July 07, 2025

Structure-based classification for differential tyrosine kinase inhibitors efficacy of EGFR exon 19 deletions in non-small cell lung cancer.

Structure-based classification for differential tyrosine kinase inhibitors efficacy of EGFR exon 19 deletions in non-small cell lung cancer.

Journal: Science China. Life sciences

Published: May 30, 2025

Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Circulating tumor DNA refines consolidation immunotherapy for limited-stage small cell lung cancer patients.

Journal: Signal transduction and targeted therapy

Published: May 08, 2025

TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study.

TROP-2-targeted antibody-drug conjugate SHR-A1921 for advanced or metastatic solid tumors: A first-in-human phase 1 study.

Journal: Cancer cell

Published: April 29, 2025

Phenotypic age acceleration and early-onset lung cancer: a case-control and prognostic cohort study involving multiple clinical centres with validation in the UK Biobank.

Phenotypic age acceleration and early-onset lung cancer: a case-control and prognostic cohort study involving multiple clinical centres with validation in the UK Biobank.

Journal: EBioMedicine

Published: April 16, 2025

Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung Cancers.

Tumor-Informed ctDNA in Guiding First-Line Immunochemotherapy in Advanced Non-Small Cell Lung Cancers.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: April 15, 2025

Developing a quality evaluation indicator system for lung cancer diagnosis and treatment: a modified Delphi method study.

Developing a quality evaluation indicator system for lung cancer diagnosis and treatment: a modified Delphi method study.

Journal: BMC cancer

Published: March 06, 2025

Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial.

Glecirasib plus sitneprotafib in patients with KRASG12C-mutated non-small-cell lung cancer in China: an open-label, multicentre, single-arm, phase 1/2a trial.

Journal: The Lancet. Respiratory medicine

Published: February 19, 2025

Showing 1-12 of 46

Last Updated: 09/26/2026